| abstract |
The invention provides modulators for the orphan nuclear receptor ROR γ and methods for treating ROR γ mediated diseases by administration of these novel ROR γ modulators to a human or a mammal in need thereof. Specifically, the present invention provides compounds of Formula (1) and the enantiomers, diastereomers, tautomers, solvates and pharmaceutically acceptable salts thereof as well as pharmaceutical compositions comprising said compounds as an active ingredient. |